Plasma derived medicinal products play a key and often unique role in the treatment of many acute and chronic pathologies.

Some of the pathologies treated with plasma-derived medicinal products

  • Congenital Immunodeficiencies

  • Neurological Diseases

  • Haemophilia and other congenital clotting disorders

  • Cirrhosis and related complications

At international level, we are witnessing an increase in their use for:

  • The identification of new therapeutic indications

  • The ageing of the population

  • An increase in diagnoses in countries with emerging economies

Self-sufficiency rates of the plasma derived medicinal products

National data year 2023

Albumin

Antithrombin

Immunoglobulins for intravenous use

Immunoglobulin for subcutaneous use

Factor VIII

Factor VIII / Factor von Willebrand

S/D virus-inactivated plasma

Factor IX

3-Factor Prothrombin complex concentrates

Fibrinogen

*The value does not include Pentaglobin™
**100% of total demand for contract-manufactured products

Plasma provided to industry 2000-2023

For monthly tracking data click here

Source:
Adapted by the CNS on data sent by the fractionation Companies, January 2024

Italian Plasma sent to the industry by category

Apheresis plasmaRecovered plasma

Source:
Adapted by the CNS on data sent by the fractionation Companies, January 2024